Sequenom Addresses Problems With Tainted Data; CEO Fired
This article was originally published in The Gray Sheet
Executive Summary
Sequenom will rely on independent third-party validation of all future tests after an investigation into SEQureDX Down syndrome test R&D data revealed mishandling by employees